Surmodics, Inc. (DELISTED) (SRDX:DL)
42.98
0.00 (0.00%)
USD |
NASDAQ |
Nov 28, 16:00
Surmodics EPS Diluted (Quarterly): -0.3724 for June 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.009 |
| Atossa Therapeutics, Inc. | -0.0673 |
| Abeona Therapeutics, Inc. | -0.0952 |
| Kiora Pharmaceuticals, Inc. | 0.0062 |
| Intellia Therapeutics, Inc. | -0.9196 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.318M |
| Revenue (Quarterly) | 29.57M |
| Total Expenses (Quarterly) | 34.88M |
| Enterprise Value | 614.36M |
| Gross Profit Margin (Quarterly) | 67.92% |
| Profit Margin (Quarterly) | -17.99% |
| Earnings Yield | -2.88% |
| Operating Earnings Yield | 0.08% |
| Normalized Earnings Yield | -1.627 |